Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Di | Kane Biotech Inc (2): Kane Biotech sale of Stem Animal interest | 1 | Stockwatch | ||
16.04. | Kane Biotech Inc (2): Kane Biotech to hold webinar April 18 | 2 | Stockwatch | ||
16.04. | Kane Biotech Inc.: Kane Biotech to Host Investor Webinar | 1 | GlobeNewswire (USA) | ||
15.04. | Kane Biotech Inc (2): Kane Biotech closes STEM interest sale | 2 | Stockwatch | ||
15.04. | Kane Biotech Inc.: Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products | 484 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, April 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) ("Kane") announces that, it has completed the sale of its interest in STEM Animal Health Inc. to... ► Artikel lesen | |
11.04. | Kane Biotech to sell its STEM Animal Health for C$11.5 million | 1 | The Market Herald Canada | ||
11.04. | Kane Biotech Inc (2): Kane Biotech signs agreement in principle for Stem sale | 1 | Stockwatch | ||
11.04. | Kane Biotech Inc (2): Kane Biotech to resume at 7:30 a.m. PT | 1 | Stockwatch | ||
11.04. | Kane Biotech Inc.: Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health | 210 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, April 11, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech") announces today that it has reached an agreement in principle for... ► Artikel lesen | |
11.04. | Kane Biotech Inc (2): Kane Biotech halted at the open | 1 | Stockwatch | ||
26.03. | Kane Biotech Inc (2): Kane Biotech loses $5.27-million in 2023 | 3 | Stockwatch | ||
26.03. | Kane Biotech Inc.: Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results | 174 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, March 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the "Company" or "Kane Biotech") today announces its fourth quarter and full year 2023 financial... ► Artikel lesen | |
20.03. | Kane Biotech Inc (2): Kane extends exclusivity period on Stem offer | 1 | Stockwatch | ||
20.03. | Kane Biotech Inc.: Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health | 1 | GlobeNewswire (USA) | ||
19.03. | Kane Biotech Inc (2): Kane Biotech to release 2023 results March 26 | 1 | Stockwatch | ||
19.03. | Kane Biotech Inc.: Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 - Conference Call to Follow | 1 | GlobeNewswire (USA) | ||
08.03. | Kane Biotech Inc.: Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award | 1 | GlobeNewswire (USA) | ||
22.02. | Kane Biotech Inc (2): Kane Biotech appoints Huizinga as executive chair | 1 | Stockwatch | ||
22.02. | Kane Biotech Inc.: Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair | 162 | GlobeNewswire (Europe) | WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the "Company" or "Kane Biotech" or "Kane") announces that at the special meeting of the shareholders... ► Artikel lesen | |
31.01. | Kane Biotech Inc (2): Kane Biotech files revyve wound gel spray patent | 1 | Stockwatch |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PAION | 0,028 | -17,06 % | Paion mit SONDERMELDUNG: Könnte die Aktie JETZT komplett drehen - Dringend vor dem Wochenende handeln! | ||
NANOREPRO | 1,845 | -0,27 % | EQS-News: NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen | EQS-News: NanoRepro AG
/ Schlagwort(e): Aktienrückkauf
NanoRepro AG: Veröffentlichung von Kapitalmarktinformationen
22.04.2024 / 12:00 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
4SC | 8,700 | +4,07 % | 4SC vor entscheidenden Monaten: "Ein arbeitsreiches Quartal" | Das Biotech-Unternehmen 4SC hat am Donnerstag seine Quartalsmitteilung vorgelegt. Gemeldet wird zum 31. März ein Bestand an Finanzmitteln in Höhe von 6,1 Millionen Euro nach 8,3 Millionen Euro per Ende... ► Artikel lesen | |
PALATIN TECHNOLOGIES | 1,640 | -3,30 % | Palatin Says Topline Results From The Phase 3 MELODY-1 Study Of PL9643 In Dry Eye Disease Positive | WASHINGTON (dpa-AFX) - Biopharmaceutical company Palatin Technologies, Inc. (PTN) Monday said it presented positive topline results from the Phase 3 MELODY-1 study of its drug candidate PL9643... ► Artikel lesen | |
BRAIN BIOTECH | 2,880 | +4,73 % | EQS-News: BRAIN Biotech AG unternimmt nächsten Schritt zur Optimierung der Gruppenstruktur | EQS-News: BRAIN Biotech AG
/ Schlagwort(e): Sonstiges
BRAIN Biotech AG unternimmt nächsten Schritt zur Optimierung der Gruppenstruktur
16.04.2024 / 11:20 CET/CEST
Für... ► Artikel lesen | |
BIOXXMED | 0,488 | +4,27 % | HV-Kalender: Aktionärs-Versammlungen u.a. bei bioXXmed, Shelly Group, Valneva | Einmal jährlich müssen sich Aufsichtsrat und Vorstand einer Gesellschaft den Aktionären stellen: Die Hauptversammlung ist das höchste Organ einer Aktiengesellschaft und vergleichbarer Unternehmens-Formen.... ► Artikel lesen | |
AAP IMPLANTATE | 0,920 | 0,00 % | aap Implantate: Lateinamerika-Geschäft bringt Umsatzplus | aap Implantate meldet Eckdaten für das erste Quartal 2024. Unternehmensangaben vom Montag zufolge konnte der Umsatz in dem Zeitraum von 2,96 Millionen Euro auf 3,12 Millionen Euro erhöht werden. Während... ► Artikel lesen | |
CLINUVEL | 9,015 | -0,50 % | CLINUVEL PHARMACEUTICALS LIMITED: Ceasing to be a substantial holder | ||
SANGAMO THERAPEUTICS | 0,493 | +1,50 % | Sangamo Therapeutics, Inc.: Sangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering | Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional investors, providing for the purchase... ► Artikel lesen | |
SCORPIUS | 0,150 | -6,25 % | Scorpius Holdings, Inc.: Scorpius Holdings Announces Receipt of Filing Delinquency Notification | DURHAM, N.C., April 22, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX), an integrated contract development and manufacturing organization (CDMO), received an official notice... ► Artikel lesen | |
AETERNA ZENTARIS | 1,810 | 0,00 % | Aeterna Zentaris Inc: Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris | TORONTO and EDMONTON, March 28, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna") and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) ("Ceapro") are pleased to announce... ► Artikel lesen | |
BIO-GATE | 1,000 | -0,99 % | EQS-News: Bio-Gate AG: Bio-Gate steigert Umsatz 2023 um gut 20 Prozent und plant weiteres Wachstum | EQS-News: Bio-Gate AG
/ Schlagwort(e): Vorläufiges Ergebnis/Sonstiges
Bio-Gate steigert Umsatz 2023 um gut 20 Prozent und plant weiteres Wachstum
22.04.2024 / 09:16 CET/CEST
Für... ► Artikel lesen | |
EDITAS MEDICINE | 4,990 | +0,44 % | Editas Medicine, Inc.: Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting | ||
TREVENA | 0,391 | +4,83 % | TREVENA INC - 8-K, Current Report | ||
EVOLVA | 1,001 | -0,72 % | Adhoc: Evolva Holding SA: Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected | Evolva Holding SA / Key word(s): AGMEGM
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction... ► Artikel lesen |